Asymchem
IPOInnovative CDMO Solutions in an Ever-Changing World
Public · Tianjin, China · Founded 1999 · $2.3B raised
- Headquarters
- Tianjin
- Employees
- 5001–10000
- Founded
- 1999
- Business Model
- B2B
- Website
- asymchem.com
- Total Funding
- $2.3B
- Last Round
- $2.3B Private EquityFeb 2020
- Rounds
- 2
- Type
- Public
About
Asymchem is a global contract development and manufacturing organization (CDMO) founded in 1999, providing integrated R&D and one-stop production services to the world's top pharmaceutical companies. The company offers comprehensive CMC services covering the full lifecycle of drug development — from early clinical stage through commercial manufacturing — including advanced intermediates, APIs, formulations, and clinical research services. Asymchem is a recognized leader in green chemistry and novel manufacturing technologies including continuous flow chemistry, biocatalysis, fermentation, and electrochemistry, enabling cost-effective and environmentally responsible pharmaceutical synthesis.
Summary
Asymchem is a Healthcare company based in Tianjin, China, founded in 1999. It has raised $2.3B in total across 2 rounds, most recently a $2.3B Private Equity round in Feb 2020. Investors include Goldman Sachs and Tianyi Medical Private Equity.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2021
Sign up to see all 3 rounds
Venture Round through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/asymchem"><img src="https://indexed.vc/api/badge/company/asymchem" alt="Asymchem on Indexed.vc" width="260" height="76" /></a>